Revenue from Contract with Customer, Excluding Assessed Tax in USD of Neuphoria Therapeutics Inc. from Q4 2024 to 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Neuphoria Therapeutics Inc. quarterly and annual Revenue from Contract with Customer, Excluding Assessed Tax history and change rate from Q4 2024 to 2025.
  • Neuphoria Therapeutics Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 31 Mar 2025 was $15,000,000.
Source SEC data
View on sec.gov
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)

Neuphoria Therapeutics Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $15,000,000 01 Jan 2025 31 Mar 2025 10-Q 20 May 2025 2025 Q3
Q4 2024 $662,715 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025 2025 Q2

Neuphoria Therapeutics Inc. Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $15,649,448 01 Jul 2024 30 Jun 2025 10-K 29 Sep 2025 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.